Business Wire

Esri Partners with International Community to Scale GIS Technology for Sustainable Development

Share

Esri, the global leader in location intelligence, today announced its contribution to an open, community-driven partnership working to accelerate the achievement of the United Nations Sustainable Development Goals (SDGs). Governments, international organizations, foundations, universities, and civil society groups are joining the initiative to offer resources and expertise, including capacity-building efforts, that will enable virtual Centers of Excellence for Geospatial Information to provide greater access to SDG data for nations in need.

“This collaboration will bring the innovations of geospatial information science to a wider public,” said Jeffrey Sachs, University Professor and Director of the Center for Sustainable Development, Columbia University, President of the UN Sustainable Development Solutions Network, SDG Advocate under UN Secretary-General António Guterres, and Chair of the Lancet COVID-19 Commission. “The virtual centers will empower communities around the world with very powerful data-driven solutions to help them implement targeted SDG changes where they are needed.”

The public and private sector collaboration’s goal is to expand adoption of SDG Data Hubs by national governments for official monitoring and reporting of SDG progress, and fostering the development of the hubs by state, provincial and local governments, NGOs, and regional entities. The hubs, powered by Esri software, allow countries to measure, monitor, and report on the SDGs in a geographic context, and make it easier for nations to collect, analyze, and share the data required to monitor progress.

“Inequality threatens long-term social and economic development, hampers poverty reduction initiatives, and the COVID pandemic along with climate change only exacerbate these problems, especially among vulnerable global communities,” said Jack Dangermond, Esri founder and president. “Our goal in this partnership is to enable the world to work more effectively together on reducing inequalities by leveraging geospatial technology to better understand and solve these challenges.”

Esri has specifically committed to provide over $15 million in technology grants for 74 of the world’s developing countries, capacity building support, and $1 million in financial resources to advance the implementation of the United Nations Integrated Geospatial Information Framework (IGIF) and the deployment of SDG Data Hubs, in close cooperation with the United Nations Global Geospatial Information Management (GGIM) Secretariat.

“The United Nations IGIF is a globally adopted multi-dimensional framework aimed at strengthening national geospatial information arrangements in countries to support national development monitoring and reporting,” said Stefan Schweinfest, Director of Statistics Division, UN Department of Economic and Social Affairs. “The IGIF provides an institutional framework for organizations to realize the creation of SDG Data Hubs, and enhanced by virtual Centers of Excellence for Geospatial Information. These much-needed mechanisms can significantly increase the ability of countries to collect, manage, and communicate policy-relevant, actionable SDG data and information at the global, national, and sub-national levels.”

The successful implementation of SDG Data Hubs by more than 15 countries over the last 4 years has established a consistent, scalable pattern for reporting on and monitoring the progress of the SDGs.However, many countries continue to face obstacles that inhibit their ability to implement SDGs, making it more difficult to support national development or economic prosperity.

The next step that this community of global stakeholder organizations seeks to undertake is to provide the resources for the broader scale-up of approximately 20 developing countries currently without the adequate technology, SDG Data Hub implementation plans, and capacity development to monitor and report on the SDGs.

“Part of our mission involves bringing together partner organizations to facilitate innovative solutions for global sustainability efforts,” said Sergio Fernández de Cordova, Executive Chairman, PVBLIC Foundation. “The SDG Data Hubs are the perfect example of cutting-edge transformative technology that is designed to help build local capacity in the areas where it is critically needed and virtual Centers of Excellence for Geospatial information would amplify this effort, using data—our greatest currency—to build a better tomorrow, one country at a time.”

The goal of this international, cross-sector partnership will ultimately be the establishment of an alliance for the SDGs between the partners as well as member states. Learn more about how Esri is supporting the global community in scaling up adoption and deployment of SDG Hubs here.

About Esri

Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com.

Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jo Ann Pruchniewski
Public Relations, Esri
Mobile: 301-693-2643
Email: jpruchniewski@esri.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SES Successfully Prices EUR 150 Million Tap of 2026 Eurobond22.6.2021 18:46:00 CEST | Press release

SES S.A. announced today the successful launch and pricing of a tap of its 1.625% Notes due 22 March 2026 in which it has agreed to sell incremental senior unsecured fixed rate notes for a total amount of EUR 150 million. The new notes were priced at 106.665% of their nominal value representing a credit spread of 47bps and a yield-to-maturity of 0.207%. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210622005953/en/ SES Successfully Prices EUR 150 Million Tap of 2026 Eurobond (Photo: Business Wire) SES is rated Baa2 by Moody’s (with negative outlook) and BBB- by Standard & Poor’s (with stable outlook). Proceeds of the issuance will be used for general corporate purposes. BBVA, Deutsche Bank and IMI Intesa Sanpaolo acted as Joint Bookrunners. The settlement is scheduled for 29 June 2021 and application has been made for the notes to be listed on the Luxembourg Stock Exchange. The securities were placed with a broad range of i

Safic-Alcan Extends Its Distribution Agreement With PMC Organometallix to the African Continent22.6.2021 18:35:00 CEST | Press release

Safic-Alcan, a global specialty chemicals distributor, is pleased to announce the extension of its distribution agreement with PMC Organometallix Inc. to the African continent. PMC Organometallix, Inc., a wholly owned subsidiary of PMC Group, N.A., Inc. has expanded its distribution agreement with Safic-Alcan to include the African continent. Effective immediately, Safic-Alcan will serve as an authorized distributor of PMC Organometallix’s FASCAT® catalysts and fine chemicals. FASCAT® catalysts are inorganic and organometallic tin compounds providing optimal conversion and curing characteristics - making these organometallic materials essential in a wide variety of applications. FASCAT® catalysts are used in the manufacture of synthetic lubricants, monomeric and polymeric ester synthesis, automotive e-coat, crosslinking of siloxanes, urethanes and chemical intermediates. “Building on our successful partnership with Safic-Alcan in continental Europe, we are pleased to extend our collabo

In Celebration of World Rainforest Day, 33 Qualified Teams and 9 Judges Announced in $10M XPRIZE Competition to Improve Understandings and Preservation of the Planet’s Rainforests22.6.2021 18:24:00 CEST | Press release

XPRIZE, the global leader in designing and operating incentive competitions to solve humanity’s grand challenges, officially announced today the teams moving forward in the $10M XPRIZE Rainforest aimed at improving our understanding of the rainforest ecosystem. Sponsored by Alana Foundation, the five-year XPRIZE Rainforest is a call-to-action to help save rainforests through the development of transformative, scalable, and affordable technology to autonomously survey and monitor biodiversity in real-time, leading to insights that communicate the health, well-being, and value of standing tropical rainforests. XPRIZE Rainforest is co-developing an inclusive framework throughout all stages of the competition that ensures competing teams co-design and co-create solutions with Indigenous Peoples and local communities as key stakeholders and not just beneficiaries. These 33 teams will now leverage existing and emerging technologies, such as robotics, remote sensing, data analysis, artificial

BourseInside, The New Media Platform That Finds Attractive Investments for Curious Investors22.6.2021 17:08:00 CEST | Press release

On the stock market, small caps continue to outperform. Since 1926, they have posted a performance of 12.1% per year, in contrast to 9.7% for large caps. And yet these so-called "small stocks" have been largely ignored by the stock market. They are rarely covered by analysts, shunned by the mainstream stock-market press and neglected by funds. Nevertheless, they are of great interest to investors, in particular those who have recently taken to investing in the stock market in order to grow their savings (16% increase in investors in 2020). For half of these newcomers, investing in the stock market gives them the opportunity to support the French economy by supporting the growth of our future champions and to channel their savings into a more sustainable and fairer model. In order to further strengthen this link between the French people and the development of our national companies, we decided to create BourseInside, the first web/TV/newsletter media platform, fully dedicated to listed

DARZALEX®▼ (daratumumab) Subcutaneous (SC) Formulation Becomes the First Approved Treatment for Newly Diagnosed Systemic Light Chain Amyloidosis in Europe and Gains an Additional Approval in Pre-Treated Multiple Myeloma22.6.2021 16:31:00 CEST | Press release

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the European Commission (EC) has granted marketing authorisation for the expanded use of DARZALEX®▼ (daratumumab) subcutaneous (SC) formulation in two new indications. The first authorisation of these new indications is for the use of daratumumab SC in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adults with newly diagnosed systemic light chain (AL) amyloidosis. This approval makes this daratumumab-based regimen the first approved therapy for AL amyloidosis in Europe. The second authorisation is for the use of daratumumab SC in combination with pomalidomide and dexamethasone (D-Pd) for the treatment of adults with multiple myeloma (MM) who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a proteasome inhibitor, and have

PPG Introduces Digital Color-Matching Device for Commercial Vehicles22.6.2021 15:02:00 CEST | Press release

PPG (NYSE: PPG) today announced the introduction of its ColorReader portable digital device, which will enable customers in the commercial vehicle sector to quickly and precisely match colors to the PPG DELFLEET ONE® color palette and international standard colors. ColorReader is a BLUETOOTH®-connected device that works with a dedicated app. Available for iOS and Android tablets and smartphones, the device provides a highly accurate color match in just a few seconds. “All users have to do is download the ColorReader app, connect with their smartphone or tablet, and place ColorReader on the painted surface to scan,” said Jo Thompson, PPG color marketing manager, automotive refinish, Europe, Middle East and Africa. “ColorReader also offers a smart solution when a smartphone or tablet is not available by instantly displaying the three closest matching colors on its built-in display after scanning.” PPG recently launched ColorReader in Europe, the Middle East and Africa, and has received a

Personalis Announces NeXT Level Biomarkers Symposium22.6.2021 15:01:00 CEST | Press release

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced its inaugural event, NeXT Level Biomarkers Symposium, which will showcase novel research into emerging biomarkers using the Personalis NeXT Platform™. This event will detail the latest research from Personalis as well as a case study done in collaboration with the Parker Institute for Cancer Immunotherapy. Presentations from Personalis will focus on recently published research into HLA loss of heterozygosity, neoantigen prediction, as well as Personalis’ novel composite biomarker, the Neoantigen Presentation Score (NEOPS™). In addition, Dr. Theresa LaVallee will be presenting findings from the PRINCE trial based on data developed and analyzed in collaboration with Personalis. The agenda for NeXT Level Biomarkers Symposium will cover: Biomarker Discovery with ImmunoID NeXT Platform® Exploring HLA LOH with the DASH (Deletion of Allele-Specific HLAs) Algorithm Neoantigen Binding Prediction and Bioma